Biological activity of a synthetic peptide with inhibin-like activity under in vitro and in vivo conditions was compared with three highly potent synthetic lutropin-releasing hormone antagonists. Unlike the synthetic lutropin-releasing hormone antagonists, which effectively inhibited both lutropin and follitropin secretion from the pituitary, the inhibin-like peptide showed a preferential effect by inhibiting follitropin release both in vitro and in vivo. Thus, small peptides such as inhibin-like peptide with a sequence unrelated to lutropinreleasing hormone may provide a basis for design of selective inhibitors of gonadotropin release.
Inhibin is a gonadal protein or peptide with the ability to selectively inhibit the secretion of follicle-stimulating hormone (FSH) from the pituitary in various assay systems (1, 2) . Advances have been made describing the structures of various molecules with inhibin-like activity. We have reported the isolation, structure, and synthesis of a 31-amino acid peptide with inhibin-like activity (ILP) (3). Subsequently, it was shown to originate from larger molecules (4) . Another polypeptide from the same source, though of a different structure, was also reported to exhibit a similar activity (5) . Several bull seminal plasma proteins (6) (7) (8) with a high degree of homology to fibronectins (8) , also inhibit gonadotropin release from the pituitary. Other studies have deduced even more complex structures for inhibin-like protein(s) from ovarian sources based on cDNA sequences (9) (10) (11) . It is apparent that in the female, besides the ovary, the placenta also has the mRNA for at least one of the chains of human ovarian inhibin protein(s) (12) . These reports serve to illustrate the molecular diversity of peptides/proteins that may influence gonadotropin secretion.
Lutropin-releasing hormone (LHRH), a decapeptide of hypothalamic origin (13) , which arises from a larger precursor, releases both lutropin (LH) and FSH from the pituitary. Since the discovery of the structure of LHRH, more than a thousand analogs (14, 15) displaying potent agonistic or antagonistic activities have been chemically synthesized in the hope of providing new potential approaches to the control of mammalian fertility and the treatment of infertility as well as for therapeutic use in controlling certain types of cancer (16) . However, due to the intrinsic LH-and FSH-releasing ability of the decapeptide, there has been no success in producing antagonistic analogs that selectively inhibit LH or FSH release. The object of this investigation was to demonstrate that, under certain in vitro and in vivo conditions, the synthetic ILP could selectively inhibit FSH release while all three LHRH antagonists, which were included for comparison, inhibited the release of both FSH and LH.
MATERIALS AND METHODS
ILP was chemically synthesized as described (17) . The synthetic LHRH analogs (Table 1) were kindly supplied by D. H. Coy.
In Vitro Incubation Procedure. Male Swiss albino mice of the Hauska strain were obtained when they were 16 days old from Charles River (Montreal). The animals were maintained until day 20 under standard laboratory conditions with their mother and with food and water ad libitum.
The incubation procedures in the current set of experiments were slight modifications of those described (18, 19) . The mice were sacrificed without anesthesia. The pituitaries were carefully removed and placed in a flask containing Dulbecco's modified Eagle's medium (DMEM, GIBCO), oxygenated with 95%02/5% CO2 at pH 7.4, and containing bovine serum albumin (Sigma) at 1 mg/ml. This medium (DMEM/bovine serum albumin) was used for dilution of all samples, which were prepared in plastic tubes immediately prior to addition. After collection, the pooled pituitaries (60-80 pituitaries) were rinsed and preincubated in 10 ml of DMEM/bovine serum albumin for 30 min at 37°C in a metabolic shaker. Following this, the medium was discarded, and the pituitaries were placed in individual 12 x 75 mm plastic tubes, to which appropriate test solutions were added. All peptides were completely soluble in the aqueous buffers employed in the assay. Sets of tubes (as indicated in Fig. 1 ) also received 3 ng of synthetic LHRH (Ayerst Laboratories, Montreal) per tube. The total incubation volume was 1 ml. After 3 hr, the medium from each tube was separated and assayed for FSH and LH immediately or stored at -20°C until analyzed.
The amounts of FSH and LH released into the medium were estimated by specific radioreceptor assays as described (19) . 125I-labeled ovine FSH and bull testicular membranes, as receptor, were used for the assay of FSH. Homogenates of adult rat testes and 1251I-labeled ovine LH were used to estimate LH in the medium. Ovine FSH and LH purified in our laboratory were used for labeling as well as standards in the assay. These methods of assay have been validated for estimating mouse FSH and LH in the medium (19) . Results were analyzed for significance by Student's t test.
Comparison of the Effects in Vivo. The effects of pretreatment of rats with ILP or LHRH antagonists subsequent to LHRH challenge was next compared in 25-day-old male rats. In these acute experiments, the test solutions prepared in 0.2% bovine serum albumin were divided into three equal volumes and administered subcutaneously at -6, -3, and 0 hr on the day of the experiment. At 0 hr, the rats were challenged with 5 ,g of synthetic LHRH. One hour later Abbreviations: ILP, peptide with inhibin-like activity; FSH, follitropin or follicle-stimulating hormone; LH, lutropin or lutenizing hormone; LHRH, LH releasing hormone.
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Medical Sciences: Sairam et al. Under in vivo conditions, a similar divergence in the action ofthe two classes of inhibitors became evident. The synthetic ILP caused a maximal suppression (60%) ( Fig. 2A) (Fig. 2B) . This trend was similar to that seen in the previous set of experiments (Fig. 1 Lower) .
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